DanCann Pharma A/S' Pre-Validation Batches Meets European Standards, paving the Path for Final Product Approval
COPENHAGEN, Denmark, 01 June 2023 - DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann Pharma" or the "Company"), a Danish biopharmaceutical company powered by cannabinoids, is pleased to announce the successful QC analysis of its pre-validation batches. The Company has confirmed that all batches have been tested in accordance with European (German and Danish) standards, meeting the required specifications and further advancing the approval process.As part of its commitment to ensuring the highest standards of quality and compliance, DanCann Pharma conducted comprehensive testing of